London
· Delayed Price · Currency is GBP · Price in GBX Creo Medical Group Company Description
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom.
It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope.
The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device.
In addition, it provides endotherapy accessories comprising injection needles, haemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology.
Further, the company offers products for diagnostic, therapeutic, and hygiene purposes. Creo Medical Group PLC was founded in 2003 and is headquartered in Chepstow, the United Kingdom.
| Country | United Kingdom |
| Founded | 2003 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 287 |
| CEO | Craig Gulliford |
Contact Details
Address: Creo House Chepstow, NP16 5UH United Kingdom | |
| Phone | 44 12 9160 6005 |
| Website | creomedical.com |
Stock Details
| Ticker Symbol | CREO |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB00BZ1BLL44 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Craig Gulliford | Chief Executive Officer |
| Richard Rees | Chief Financial Officer |